NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The ECA guidance should be published in final version sometime between now and first week of April. The idea is that the MHRA is supposed to give companies time to prepare before these various trial/marketing application guidelines become mandatory April 28.

Of course, once published, if mandatory is not a concern either way, a marketing decision could come sooner than April 28, which still allows parties (sponsor/regulator) to point to the then already published guideline for reasoning/backing.